Twinbeech Capital LP Axogen, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.67 - $8.06 $263,258 - $374,225	46,430 New	46,430 $336,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $168,734 - $253,930	20,729 New	20,729 $247,000
Q3 2021 Nov 15, 2021	SELL	$15.23 - $21.72 $187,968 - $268,068	-12,342 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.8 - $23.5 $219,687 - $290,037	12,342 New	12,342 $267,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.